• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 4. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 5. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792

Ethyl 2-bromo-4-methylbenzoate (CAS No. 155694-82-9): A Versatile Intermediate in Modern Chemical Synthesis

Ethyl 2-bromo-4-methylbenzoate (CAS No. 155694-82-9) is a significant compound in the realm of organic synthesis, serving as a crucial intermediate in the development of various pharmaceuticals, agrochemicals, and specialty chemicals. Its molecular structure, featuring a brominated aromatic ring and an ester functional group, makes it a valuable building block for further chemical modifications. This introduction delves into the compound's properties, synthesis methods, and its growing prominence in contemporary research applications.

The molecular formula of Ethyl 2-bromo-4-methylbenzoate is C₁₀H₉BrO₂, with a molecular weight of approximately 254.06 g/mol. The presence of both bromine and ester groups imparts unique reactivity to the compound, enabling diverse synthetic pathways. The bromine atom at the 2-position enhances electrophilic aromatic substitution reactions, while the ester group can undergo hydrolysis or transesterification, facilitating the introduction of other functional groups.

In recent years, Ethyl 2-bromo-4-methylbenzoate has garnered attention in the pharmaceutical industry due to its role as a precursor in the synthesis of bioactive molecules. For instance, it has been utilized in the preparation of nonsteroidal anti-inflammatory drugs (NSAIDs) and kinase inhibitors. The bromine substituent allows for further functionalization via cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings, which are pivotal in constructing complex heterocyclic frameworks.

One notable application of Ethyl 2-bromo-4-methylbenzoate is in the development of small-molecule inhibitors targeting therapeutic targets. Researchers have leveraged its structural features to design compounds with enhanced binding affinity and selectivity. For example, derivatives of this compound have been explored as potential inhibitors of Janus kinases (JAKs), which play a critical role in inflammatory responses and autoimmune diseases. The ability to modify both the aromatic ring and the ester moiety provides a high degree of flexibility in optimizing pharmacological properties.

The synthesis of Ethyl 2-bromo-4-methylbenzoate typically involves the bromination of methyl benzoate followed by esterification. Alternatively, direct bromination of ethyl 4-methylbenzoate can be employed, depending on the available starting materials and desired yields. Advanced synthetic techniques, such as catalytic hydrogenation or palladium-catalyzed reactions, have been optimized to improve efficiency and reduce byproduct formation.

The compound's stability under various conditions makes it suitable for long-term storage and transportation, ensuring its availability for industrial-scale applications. However, handling should be performed with standard laboratory precautions due to its potential reactivity with strong nucleophiles or bases. Solubility studies have shown that Ethyl 2-bromo-4-methylbenzoate exhibits moderate solubility in organic solvents like dichloromethane and ethyl acetate but limited solubility in water.

Recent advancements in green chemistry have prompted investigations into sustainable synthetic routes for Ethyl 2-bromo-4-methylbenzoate. Researchers are exploring biocatalytic methods and microwave-assisted synthesis to minimize energy consumption and waste generation. These innovations align with global efforts to promote environmentally friendly practices in chemical manufacturing.

The role of computational chemistry in designing derivatives of Ethyl 2-bromo-4-methylbenzoate cannot be overstated. Molecular modeling techniques have enabled researchers to predict the binding modes of potential drug candidates with high accuracy. This approach has accelerated the discovery process by allowing virtual screening of large libraries of compounds before experimental synthesis.

In conclusion, Ethyl 2-bromo-4-methylbenzoate (CAS No. 155694-82-9) is a multifaceted compound with broad applications in pharmaceutical research and industrial chemistry. Its unique structural features facilitate diverse synthetic transformations, making it an indispensable intermediate for developing novel bioactive molecules. As research continues to evolve, this compound is expected to remain at the forefront of chemical innovation.

• 155694-83-0(Benzoic acid,2-bromo-3-methyl-, ethyl ester)
• 485832-16-4(benzyl 2,5-dibromobenzoate)
• 49619-44-5(2-Bromobenzoic anhydride)
• 154239-21-1(1,4-Diethyl 2-bromobenzene-1,4-dicarboxylate)
• 90772-73-9(4-(Acetoxymethyl)-3-bromobenzoic acid)
• 54364-80-6(benzoic acid, 2,3-dibromo-, ethyl ester)
• 56984-35-1(1,3-Benzenedicarboxylic acid, 4-bromo-, diethyl ester)
• 1214375-69-5(Ethyl 2,6-dibromobenzoate)
• 6091-64-1(Ethyl 2-bromobenzoate)
• 18013-97-3(Diethyl 2,5-Dibromoterephthalate)